Serum Biomarkers in Advanced-Stage AIDS-Associated Kaposi Sarcoma in Resource Limited Settings
Marta Epeldegui(University of California, Los Angeles), Thomas Campbell(University of Colorado Anschutz Medical Campus), Carlee Moser(Harvard University), Margaret Borok(University of Zimbabwe), Wadzanai Samaneka(University of Zimbabwe), Naftali Busakhala(Moi University), Susan E. Krown(Memorial Sloan Kettering Cancer Center), Patrick MacPhail(University of the Witwatersrand), Mulinda Nyirenda(University of Malawi), Otoniel Martı́nez-Maza(University of California, Los Angeles), Josphat Kosgei(United States Army Medical Research Directorate - Africa), Mina C. Hosseinipour, Younjung Choi(Massachusetts Department of Public Health)
Cited by 0
Related Papers
Kaposi sarcoma
|Nature Reviews Disease Primers|2019|707
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
|New England Journal of Medicine|2021|661
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
|New England Journal of Medicine|2021|548
Alterations in the Gut Microbiota Associated with HIV-1 Infection
|Cell Host & Microbe|2013|508